An official website of the United States government
NIH Guide: Weekly Index for October 20, 2023
Weekly NIH Guide Notices
October 20, 2023
Policy Notices
-
Simplified Review Framework for NIH Research Project Grant Applications
(NOT-OD-24-010)National Institutes of Health
General Notices
-
Notice of Pre-Application Webinars for RFA-AG-24-040, Microphysiological Systems to Advance Precision Medicine for AD/ADRD Treatment and Prevention (U54 Clinical Trial Not Allowed)
(NOT-AG-23-067)National Institute on Aging
-
Notice of Joint NSF/NIDA Initiative to Support Research in the Incorporating Human Behavior into Epidemiological Models Program
(NOT-DA-23-038)National Institute on Drug Abuse
-
Notice of NIDCR Participation in RFA-NS-23-006, "HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 Clinical Trial Not Allowed)"
(NOT-DE-24-004)National Institute of Dental and Craniofacial Research
-
Notice of NIDCR Participation in RFA-NS-23-007, "HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed)"
(NOT-DE-24-005)National Institute of Dental and Craniofacial Research
-
Notice of Availability of Frequently Asked Questions (FAQs) for PAR-23-289: Diagnostic Centers of Excellence for the Undiagnosed Diseases Network (U01 Clinical Trial Not Allowed)
(NOT-NS-23-112)National Institute of Neurological Disorders and Stroke
-
Solicitation of Nominations for the 2024 National Institute of Neurological Disorders and Stroke (NINDS) Landis Award for Outstanding Mentorship
(NOT-NS-24-026)National Institute of Neurological Disorders and Stroke
-
Online Briefing on NIHs Simplified Peer Review Framework for NIH Research Project Grant (RPG) Applications: for Applicants and Reviewers
(NOT-OD-24-012)National Institutes of Health
-
Showcase Opportunities for NIH Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Awardees
(NOT-OD-24-013)Office of the Director, NIH
-
Notice to Close Funding Opportunity Announcement RFA-OH-22-001: NIOSH Education and Research Centers
(NOT-OH-24-001)National Institute for Occupational Safety and Health
-
NIH Request for Information (RFI) on Research Opportunities Related to HIV and Womens Health
(NOT-OD-24-011)Office of Research on Women's HealthOffice of AIDS Research
Notice of Changes to Funding Opportunities
-
Notice of Change to Key Dates Listed in RFA-AG-24-030, " Consortium for Economic Research on AD/ADRD Prevention, Treatment, and Care Coordinating Center (U54 Clinical Trial Optional)"
(NOT-AG-23-066)National Institute on Aging
-
Notice of Change to Other Attachments in PAR-23-284 "Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2024, 2025, and 2026 (P50 Clinical Trial Required)
(NOT-CA-23-097)National Cancer Institute
-
Notice of Change to section for RFA-DA-24-026, "NIDA REI: Academic Research Enhancement Award (AREA) Training a Diverse Data Science Workforce for Addiction Research (R15 Clinical Trial Not Allowed)"
(NOT-DA-23-039)National Institute on Drug Abuse
-
Notice of Change to Award Budget for PHS 2023-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Grant Applications
(NOT-OD-24-014)Office of the Director, NIH
-
Notice of Correction to Budget Instructions for RFA-RM-23-019 " Human Virome Characterization Centers (U54 Clinical Trial Not Allowed)
(NOT-RM-23-026)Office of Strategic Coordination (Common Fund)
Notices of Intent to Publish
-
Notice of Intent to Publish the Reissuance of RFA-AG-20-020, "Nathan Shock Centers of Excellence in Basic Biology of Aging (P30 Clinical Trial Not Allowed)"
(NOT-AG-23-062)National Institute on Aging
-
Notice of Intent to Publish the Reissuance of RFA-AG-20-021, "Nathan Shock Centers Coordinating Center (U24 Clinical Trial Not Allowed)"
(NOT-AG-23-063)National Institute on Aging
-
Notice of Intent to Publish a Funding Opportunity Announcement for Geroscience Course (R25 Independent Clinical Trial Not Allowed)
(NOT-AG-23-065)National Institute on Aging
-
Notice of Intent to Publish a Funding Opportunity Announcement for National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
(NOT-CA-23-096)National Cancer Institute
-
Notice of Intent to Publish a Funding Opportunity Announcement for Cardiovascular Repository Type 1 Diabetes (CARE-T1D) Consortium (U01 Clinical Trial Not Allowed).
(NOT-DK-24-001)National Institute of Diabetes and Digestive and Kidney DiseasesNational Heart, Lung, and Blood Institute
Notices of Special Interest
-
Notice of Special Interest (NOSI): Administrative Supplement to Support Research Opportunities at NIAID Intramural Facilities
(NOT-AI-23-074)National Institute of Allergy and Infectious Diseases
-
Notice of Special Interest (NOSI): Research Projects to Develop Oncoaging Models for Cancer Research
(NOT-CA-23-092)National Cancer InstituteNational Institute on Aging
-
Notice of Special Interest (NOSI): Palliative Care in the Care Continuum among Persons with Serious Heart, Lung, Blood and Sleep (HLBS) Diseases and their Caregivers
(NOT-HL-23-117)National Heart, Lung, and Blood InstituteNational Institute on Minority Health and Health Disparities
Funding Opportunities
-
Leveraging Extant Data to Understand Developmental Trajectories of Late Talking Children (R21 Clinical Trial Not Allowed)
(PAR-24-045)National Institute on Deafness and Other Communication DisordersEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Mental HealthNational Center for Advancing Translational SciencesOffice of Behavioral and Social Sciences ResearchNational Center for Advancing Translational SciencesApplication Receipt Date(s): November 19, 2024
-
Information and Practice Needs Relevant to Late Talking Children (R21 Clinical Trial Not Allowed)
(PAR-24-046)National Institute on Deafness and Other Communication DisordersEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Center for Advancing Translational SciencesOffice of Behavioral and Social Sciences ResearchNational Center for Advancing Translational SciencesApplication Receipt Date(s): November 19, 2024
-
NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)
(PAR-24-050)National Institute on Deafness and Other Communication DisordersApplication Receipt Date(s): January 5, 2025
-
NIDCD Low Risk Clinical Trials in Communication Disorders (R01 Clinical Trial Required)
(PAR-24-051)National Institute on Deafness and Other Communication DisordersApplication Receipt Date(s): May 23, 2025
-
Understanding the Impact of Healthcare System and Clinician Factors on Disparities in Maternal Morbidity and Mortality (R01 - Clinical Trial Optional)
(PAR-24-059)National Institute on Minority Health and Health DisparitiesNational Institute of Arthritis and Musculoskeletal and Skin DiseasesEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Mental HealthNational Institute of Nursing ResearchOffice of Research on Women's HealthOffice of Disease PreventionApplication Receipt Date(s): May 23, 2025
-
Comprehensive Alcohol-HIV/AIDS Research Center (P60 Clinical Trial Optional)
(RFA-AA-23-004)National Institute on Alcohol Abuse and AlcoholismApplication Receipt Date(s): April 18, 2024
-
Microphysiological Systems to Advance Precision Medicine for AD/ADRD Treatment and Prevention (U54 Clinical Trial Not Allowed)
(RFA-AG-24-040)National Institute on AgingApplication Receipt Date(s): February 15, 2024
-
Translational Research Toward Development of a Kaposi Sarcoma Herpesvirus (KSHV) Vaccine (U01 Clinical Trial Optional)
(RFA-CA-24-006)National Cancer InstituteApplication Receipt Date(s): Not Applicable
-
Applying Imaging Pipelines for Spatial Characterization of Cellular Interactions in HIV-related CNS Pathology and/or Substance Use (R61/R33 Clinical Trial Not Allowed)
(RFA-DA-24-030)National Institute on Drug AbuseApplication Receipt Date(s): February 8, 2024
-
Targeting Inflammasomes in HIV and Substance Use (R01 Clinical Trial Not Allowed)
(RFA-DA-25-012)National Institute on Drug AbuseApplication Receipt Date(s): October 28, 2024
-
Targeting Inflammasomes in HIV and Substance Use (R21 Clinical Trial Not Allowed)
(RFA-DA-25-013)National Institute on Drug AbuseApplication Receipt Date(s): October 28, 2024
-
Silvio O. Conte Digestive Diseases Research Core Centers (P30 Clinical Trial Optional)
(RFA-DK-25-003)National Institute of Diabetes and Digestive and Kidney DiseasesApplication Receipt Date(s): October 23, 2024
-
HEAL Initiative: Limited Competition: Clinical Centers for Completion of the Outcomes of Babies with Opioid Exposure (OBOE) Study (UG1 Clinical Trial Not Allowed)
(RFA-HD-24-014)Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Center for Complementary and Integrative HealthApplication Receipt Date(s): December 19, 2023
-
HEAL Initiative: Limited Competition: Data Coordinating Center for Completion of the Outcomes of Babies with Opioid Exposure (OBOE) Study (U24 Clinical Trial Not Allowed)
(RFA-HD-24-015)Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Center for Complementary and Integrative HealthApplication Receipt Date(s): December 19, 2023
-
Research Centers in Minority Institutions (RCMI) (U54 - Clinical Trial Optional)
(RFA-MD-24-001)National Institute on Minority Health and Health DisparitiesApplication Receipt Date(s): December 18, 2023
-
Efficacy and Safety of Amyloid-Beta Directed Antibody Therapy in Mild Cognitive Impairment and Dementia with Evidence of Both Amyloid-Beta and Vascular Pathology (U01 - Clinical Trial Required)
(RFA-NS-24-013)National Institute of Neurological Disorders and StrokeNational Institute on AgingApplication Receipt Date(s): June 13, 2024
-
Down Syndrome Cohort Research Sites (DS-CRS) for the Down Syndrome Cohort Study Program (DS-CDP) across the lifespan for the INCLUDE Project (U01 Clinical Trial Not Allowed)
(RFA-OD-24-003)Office of the Director, NIHNational Institute on AgingNational Institute of Arthritis and Musculoskeletal and Skin DiseasesEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Human Genome Research InstituteNational Heart, Lung, and Blood InstituteApplication Receipt Date(s): December 15, 2023
-
Federated Biobanking resource for the Down Syndrome Cohort Study Program (DS-CDP) across the lifespan for the INCLUDE Project (U24 Clinical Trial Not Allowed)
(RFA-OD-24-004)Office of the Director, NIHNational Institute on AgingNational Institute of Diabetes and Digestive and Kidney DiseasesEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Human Genome Research InstituteApplication Receipt Date(s): December 15, 2023
-
Down Syndrome Clinical Cohort Coordinating Center (DS-4C) for the INCLUDE Project (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) (U54 Clinical Trial Not Allowed)
(RFA-OD-24-005)Office of the Director, NIHNational Institute on AgingNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Institute of Diabetes and Digestive and Kidney DiseasesEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Human Genome Research InstituteNational Heart, Lung, and Blood InstituteApplication Receipt Date(s): January 26, 2024
NIH Guide Notices are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
For technical issues E-mail OER Webmaster